Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as mitomycin C and ifosfamide, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving mitomycin C together with ifosfamide
works in treating patients with metastatic pancreatic cancer.